On January 13, 2026, The Clorox Company launched Clorox™ PURE™ Allergen Neutralizer, marking its entry into the air care category. The new line consists of a daily Air Spray for living spaces and a Fabric & Carpet Spray for soft surfaces such as upholstery, curtains and bedding. Powered by a plant-based active ingredient and Aller-Fresh™ Technology, the sprays neutralize non-living allergens—pollen, dust mite matter and pet dander—by altering the protein structure to prevent receptor binding in the human body. Available in four hypoallergenic fragrances (Clean Breeze, Ocean Mist, Nighttime Calm and Energizing Citrus), Clorox™ PURE™ extends the company’s homecare portfolio into everyday wellness solutions and is now on shelves at national retailers including Walmart and Amazon.

Nineteen brokerages currently cover Clorox, assigning an average rating of “Reduce.” Among these, four analysts recommend a sell, fourteen advise holding, and one issues a buy. In its most recent quarter, Clorox delivered adjusted EPS of $0.85, topping consensus by $0.07, on revenue of $1.43 billion—a year-over-year decline of 18.9%. The company reported a net margin of 11.7% and return on equity of 358.4%. For fiscal 2026, guidance calls for EPS in the range of 5.950–6.300. Clorox also declared a quarterly dividend of $1.24 per share (annualized $4.96), reflecting a payout ratio of 77.9% and a yield of approximately 4.7%, payable mid-February to shareholders of record in late January.